euportal twitter euportal facebook

COVID -19 vaccine: Statement by von der Leyen on Moderna

COVID -19

24.11.2020 – “This contract allows us to buy up to 160 million doses of a vaccine produced by Moderna. According to the results of clinical trials, this vaccine could be highly effective against COVID-19. Once the vaccine is indeed proven as safe and effective, every Member State will receive it at the same time, on [...]

Read more

Research project support

COVID - 19 2

11.9.2020 – The Commission announced today that it will support with €4 million a new research project, SUPPORT-E, that will coordinate efforts to determine if COVID-19 convalescent plasma transfusion – using plasma from patients who recovered from the disease – is an effective and safe treatment. The funding is part of the Commission’s €1 billion [...]

Read more

Commission and EIB provide loan for CureVac for vaccine development

COVID -19

6.7.2020 – The European Investment Bank (EIB) and CureVac, a clinical-stage biopharmaceutical company developing a new class of transformative medicines based on optimised mRNA, entered into a €75 million loan agreement to support the Company’s ongoing development of vaccines against infectious diseases, including its vaccine candidate CVnCoV aimed at preventing SARS-CoV-2 infections. In addition, the [...]

Read more